Prof. Junjie Liu | pharmaceutics | Best Researcher Award

professor, Zhengzhou University, China

Liu Junjie is a professor and PhD supervisor at the School of Pharmacy, Zhengzhou University. 🎓 He completed his PhD in pharmaceutical sciences from Chongqing University in 2018. 📚 With over 40 publications in top journals like Sci Adv and Adv Mater, he is a recognized leader in his field. 🧬 He has led 10 major research projects, including grants from the National Natural Science Foundation of China. 🌍 Liu has received multiple prestigious honors, including youth talent support and high-level talent awards. 🚀 His contributions in pharmaceutical science are shaping the future of health and medicine.

Profile

Education🎓

Liu Junjie obtained his PhD in pharmaceutical sciences from Chongqing University in 2018. 🏫 His advanced training in pharmaceutical sciences allowed him to develop expertise in drug development and pharmaceutical research. 📑 His education combined rigorous theoretical knowledge and hands-on experience in the laboratory, equipping him with the tools necessary for groundbreaking research. 🧪 He also pursued further professional development through leading postdoctoral research, continuously building on his PhD training. 💡 His academic foundation serves as the cornerstone for his innovative work in drug discovery and therapeutic development.

Experience🧑‍🏫

Liu Junjie is currently a professor and PhD supervisor at Zhengzhou University’s School of Pharmacy. 🔬 He has extensive experience leading pharmaceutical research and managing collaborative research projects. 🧑‍🔬 Since completing his PhD, he has overseen 10 major research projects, including those supported by the National Natural Science Foundation of China. 🌟 His work has been featured in over 40 SCI-indexed publications as the first or corresponding author, showcasing his strong research output. 🌿 Liu is also actively involved in mentorship, guiding PhD students and shaping the next generation of pharmaceutical scientists.

Awards and Honors🏆

Liu Junjie has received numerous prestigious awards for his contributions to pharmaceutical research. 🎖️ Notably, he has been recognized by the China Association for Science and Technology with the Youth Talent Support award. 🌟 His high-level talent and innovative contributions to the field have earned him recognition in Henan Province, where he received the High-level Talent Award and was named an Outstanding Youth Talent in the Central Plains. 💼 Additionally, he was awarded the Innovative Talent Award for his role in advancing pharmaceutical research at Henan’s Higher Education Institutions.

Research Focus🔬

Liu Junjie’s research focuses on the development of innovative drugs and therapeutic treatments. 🧪 His work aims to bridge the gap between basic pharmaceutical sciences and clinical applications, exploring drug delivery systems and novel therapeutic materials. 🧬 He is particularly interested in precision medicine and the design of targeted therapies to improve treatment efficacy and minimize side effects. 🌍 His interdisciplinary research integrates chemistry, biology, and materials science to advance drug development, leading to over 40 high-impact publications in renowned scientific journals. 📈 His research aims to transform healthcare and patient outcomes.

Publication Top Notes

In situ implantable DNA hydrogel for diagnosis and therapy of postoperative rehemorrhage following intracerebral hemorrhage surgery

Published in: Science Advances (2024, 10(33), ado3919)
Authors: Yu, W., Gong, E., Wang, C., Liu, J., Shi, J.
Overview: This research focuses on a DNA hydrogel that can be implanted in situ to diagnose and treat rehemorrhage after intracerebral hemorrhage surgery, providing a new tool for post-surgical care.

2. In situ formation of biohybrid system based on Streptococcus pneumoniae for enhanced radical therapy against tumors

Published in: Cell Reports Physical Science (2024, 5(7), 102074)
Authors: Zhao, X., Wang, Q., Dong, H., Liu, J., Shi, J.
Overview: The study explores a biohybrid system using Streptococcus pneumoniae for improved radical cancer therapies, targeting tumors more effectively.

3. Retraction Note: Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade

Published in: Journal of Nanobiotechnology (2024, 22(1), pp. 302)
Authors: Wang, S., Yin, N., Li, Y., Si, P., Liu, J.
Overview: This article was retracted, but it originally examined how copper-based frameworks prevent breast cancer metastasis by blocking estrogen and platelets.

4. A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment

Published in: Advanced Science (2024, 11(17), 2305877)
Authors: Yin, N., Wang, W., Pei, F., Wang, Z.-H., Liu, J.
Overview: The research proposes a nanoplatform that hijacks neutrophils to treat ischemic stroke by modulating microglia polarization.

5. Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence

Published in: Advanced Materials (2024, 36(14), 2307923)
Authors: Geng, S., Guo, P., Wang, J., Shi, J., Liu, J.
Overview: This article focuses on an optical sensor integrated with a hydrogel to detect and remove microtumors post-surgery, reducing cancer recurrence risk.

6. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral Fusobacterium nucleatum Synergizes with PD-L1 Blockade against Breast Cancer

Published in: ACS Nano (2024, 18(12), pp. 8971–8987)
Authors: Geng, S., Guo, P., Li, X., Liu, J., Yang, Y.
Overview: This study examines a nanovehicle that targets Fusobacterium nucleatum within tumors to boost the effectiveness of PD-L1 blockade therapies for breast cancer.

Conclusion

Liu Junjie is an excellent candidate for the Best Researcher Award. His robust academic output, leadership in research projects, mentorship, and numerous recognitions make him well-suited for this prestigious recognition. While expanding his international collaborations and increasing the practical application of his research could further enhance his candidacy, his contributions to pharmaceutical sciences and his leadership in innovative research projects make him a strong contender for this award.

Assist Prof Dr. Ismail BOLAT : Leading Researcher in Pathology

Pathologist at Pathology , Atatürk university, Turkey

He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Doctorate, Ataturk University, Sağlık Bilimleri Enstitüsü, Veteriner PatolojiAnabilimDalıBaşkanlığı,Turkey2017 -2022 Undergraduate, Ataturk University, Veteriner Fakültesi,Turkey2012 -2017

Academic and Administrative Experience:

Dr. Ismail BOLAT is currently serving as the Deputy Head of Department in the Veterinary Faculty, Preclinical Sciences at Ataturk University, a position they have held since 2023. They are also a member of the Unit Quality Commission, Assistant Coordinator, Academic Council Member of the Department, and a member of the Education and Curriculum Board, all within the Veterinary Faculty’s Preclinical Sciences department at Ataturk University. Dr. Ismail BOLAT has been actively involved in various administrative and academic roles, showcasing their commitment to the development and enhancement of the department’s academic programs and overall quality. Their contributions to accreditation, continuous improvement, and renewal activities further demonstrate their dedication to maintaining high standards of education and research within the department.

Courses:

Dr. Ismail BOLAT has been actively involved in teaching various courses in the field of pathology at both the undergraduate and postgraduate levels. Their teaching experience includes courses such as General Pathology, Graduation Thesis I, Pathology of Digestive and Respiratory System Diseases, Tumor Science, Pathology of Nervous and Muscular System Diseases, Maturation Education, Necropsy, Special Pathology I and II, Basic Pathology, and Graduation Thesis II. These courses cover a wide range of topics in pathology, reflecting Dr. [Name]’s expertise and commitment to educating students in this field. Their teaching portfolio demonstrates a comprehensive understanding of pathology and its various subfields, contributing significantly to the academic development of students in the medical sciences.

Awards:

Dr. Ismail Bolat has been involved in several research projects focusing on various aspects of pharmacology and toxicology. These projects include:

Investigating the anxiolytic and circadian regulatory effects of agarwood water extract and its impact on the next generation using a zebrafish model (Tübitak, November 2023).
Studying the potential of carnosic acid in ameliorating indomethacin-induced gastric ulceration in rats by alleviating oxidative stress and inflammation (Tübitak, November 2023).
Demonstrating self-healing properties in imidacloprid toxicity through the use of multiple biomarkers and biological pathways (Tübitak, November 2023).
Exploring the effects of global warming and nanoplastic toxicity on fish health, focusing on how small temperature increases can exacerbate gill and liver toxicity caused by polystyrene nanoplastics in adult zebrafish models (Tübitak, November 2023).
Investigating the antiulcerative effects of flavonoid-rich Sambucus nigra berry extract through the activation of the Nrf2/HO-1 signaling pathway in vivo (Tübitak, November 2023).

Junjie Liu | pharmaceutics | Best Researcher Award